Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2023
DOI: 10.1016/j.jconrel.2023.10.052
|View full text |Cite
|
Sign up to set email alerts
|

Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis

Ariane Mwema,
Giulio G. Muccioli,
Anne des Rieux
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 255 publications
0
1
0
Order By: Relevance
“… 47 These nano-sized lipid carriers show significant potential for efficiently transporting therapeutic agents to the CNS. 48 Key advancements in the utilization of lipid nanoparticles for CNS applications include: enhanced BBB permeability: LNPs have been intricately engineered to augment the delivery of drugs across the BBB in small animals. 6 Modifications in LNP composition and surface characteristics facilitate their passage through the BBB, predominantly through receptor-mediated transport.…”
Section: Gene Delivery Vectorsmentioning
confidence: 99%
“… 47 These nano-sized lipid carriers show significant potential for efficiently transporting therapeutic agents to the CNS. 48 Key advancements in the utilization of lipid nanoparticles for CNS applications include: enhanced BBB permeability: LNPs have been intricately engineered to augment the delivery of drugs across the BBB in small animals. 6 Modifications in LNP composition and surface characteristics facilitate their passage through the BBB, predominantly through receptor-mediated transport.…”
Section: Gene Delivery Vectorsmentioning
confidence: 99%